Systems and methods for corneal cross-linking with pulsed light
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61M-037/00
A61F-009/00
A61F-009/007
A61N-005/06
A61K-041/00
A61K-031/525
A61F-009/013
A61F-009/008
출원번호
US-0665495
(2012-10-31)
등록번호
US-9707126
(2017-07-18)
발명자
/ 주소
Friedman, Marc D.
Kamaev, Pavel
Sherr, Evan
Eddington, William
Rood-Ojalvo, Sara
Muller, David
출원인 / 주소
Avedro, Inc.
대리인 / 주소
McDonnell Boehnen Hulbert & Berghoff LLP
인용정보
피인용 횟수 :
0인용 특허 :
79
초록▼
A method for controlling activation of Riboflavin applied to an eye includes applying the Riboflavin to a selected region of a cornea of the eye and initiating cross-linking activity in the selected region by activating the Riboflavin with pulsed light illumination. The pulsed light illumination has
A method for controlling activation of Riboflavin applied to an eye includes applying the Riboflavin to a selected region of a cornea of the eye and initiating cross-linking activity in the selected region by activating the Riboflavin with pulsed light illumination. The pulsed light illumination has an irradiance, dose, and an on/off duty cycle. The irradiance, the dose, and the on/off duty cycle are adjusted in response to a determination of photochemical kinetic pathways for Riboflavin cross-linking activity and to control photochemical efficiency.
대표청구항▼
1. A system for dynamically controlling an amount of cross-linking in a cornea, comprising: a light source configured to activate cross-linking activity in a selected region of a cornea treated with a cross-linking agent, the light source being configured to deliver pulsed light illumination accordi
1. A system for dynamically controlling an amount of cross-linking in a cornea, comprising: a light source configured to activate cross-linking activity in a selected region of a cornea treated with a cross-linking agent, the light source being configured to deliver pulsed light illumination according to parameters including at least one of a frequency, an irradiance, a dose, or an on/off duty cycle; anda controller coupled to the light source and configured to determine, based on a proposed set of the parameters for the light source, a calculated amount of cross-linking activity generated by reactions not involving singlet molecular oxygen and to adjust one or more of the parameters for the light source according at least to the calculated amount of cross-linking activity, in order to generate a desired amount of cross-linking activity in the selected region of the cornea,wherein the controller is configured to cause the light source to apply the pulsed light illumination to the selected region of the cornea according at least to the one or more adjusted parameters. 2. The system of claim 1, further comprising a delivery device configured to provide a concentration of oxygen to a surface of the cornea. 3. The system of claim 2, wherein the delivery device is configured to first provide a first gas mixture that determines a first O2 content in the cornea and secondly provide a second gas mixture that determines a second O2 content in the cornea, the first gas mixture and the second gas mixture providing different amounts of O2, the delivery device providing dynamic control of cross-linking in the cornea. 4. The system of claim 2, wherein the delivery device is configured to adjust an amount of oxygen delivered to the surface of the cornea according to the calculated amount of cross-linking activity generated by reactions not involving singlet molecular oxygen. 5. The system of claim 4, wherein the delivery device is configured to reduce the amount of oxygen delivered to the surface of the cornea. 6. The system of claim 2, wherein the delivery device is configured to provide a plurality of different, non-zero concentrations of oxygen to the surface of the eye, and the controller is configured to determine one of the plurality of concentrations of oxygen and cause the delivery device to provide the determined one of the plurality of concentrations of oxygen to the surface of the eye. 7. The system of claim 1, wherein the irradiance is between approximately 1 mW/cm2 to approximately 500 mW/cm2 and the on/off duty cycle is between approximately 100/1 to approximately 1/100. 8. The system of claim 1, wherein the pulsed light illumination has a pulse rate between approximately 0.1 Hz to approximately 1000 Hz. 9. The system of claim 1, wherein the irradiance is between approximately 1 mW/cm2 to approximately 1000 mW/cm2 and the on/off duty cycle is between approximately 1000/1 to approximately 1/1000. 10. The system of claim 1, wherein the pulsed light illumination has a pulse rate between approximately 1000 Hz to approximately 100,000 Hz. 11. The system of claim 1, wherein the light source is further configured to apply the pulsed light illumination to different regions of the cornea according to different respective on/off duty cycles in response to the controller. 12. The system of claim 1, wherein the light source is further configured to apply the pulsed light illumination and continuous wave illumination to different regions of the cornea according to different respective on/off duty cycles in response to the controller. 13. The system of claim 1, wherein the pulsed light illumination corresponds to absorption peaks of the cross-linking agent. 14. The system of claim 1, wherein the cross-linking agent includes Riboflavin with a concentration of Riboflavin between about 0.001% to about 1%. 15. The system of claim 14, wherein the controller determines the calculated amount of cross-linking activity from reactions not involving singlet molecular oxygen by determining a reaction between triple excited Riboflavin and a corneal substrate. 16. The system of claim 15 wherein, the controller adjusts one or more of the parameters for the light source to control a rate of return of the reduced form of Riboflavin to the ground state. 17. The system of claim 14, wherein the controller determines the calculated amount of cross-linking activity according at least to the following reactions: Rf3*+SH→RfH.+S., and2RfH.→Rf+RfH2, where Rf represents Riboflavin in a ground state, Rf represents Riboflavin in a triplet excited state, RfH. represents a radical form of Riboflavin, RfH2 represents a reduced form of Riboflavin, SH represents a corneal substrate, and S. represent a corneal substrate radical. 18. The system of claim 1, wherein the light source applies the pulsed light illumination according to a selected pattern corresponding to the selected region of the cornea. 19. The system of claim 1, wherein the controller further determines the calculated amount of cross-linking activity based at least on one of a proposed concentration of the cross-linking agent or a proposed soak time for the treatment of the cross-linking agent. 20. The system of claim 1, wherein the controller adjusts one or more of the parameters for the light source to increase an actual amount of cross-linking activity generated by reactions not involving singlet molecular oxygen. 21. The system of claim 1, wherein the light source includes a digital micro-mirror device (DMD) including a plurality of mirrors, each mirror representing one or more pixels for the pulsed light illumination.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (79)
Peyman,Gholam A., Adjustable inlay with multizone polymerization.
Nelson J. Stuart ; Milner Thomas E. ; Svaasand Lars O.,NOX, Apparatus and method for dynamic cooling of biological tissues for thermal mediated surgery.
Utzinger, Urs; Durkin, Anthony J.; Fuchs, Holger; Gillenwater, Ann M.; Heintzelman, Douglas L.; Richards-Kortum, Rebecca R., Combined fluorescence and reflectance spectroscopy.
Kelman Charles D. (269 Grand Central Pkwy. Floral Park NY 11005) DeVore Dale P. (3 Warwick Dr. Chelmsford MA 01824), Human collagen processing and autoimplant use.
Driller Jack (Ridgewood NJ) Faulkenberry William J. (Long Island City NY) Lizzi Frederic L. (Tenafly NJ), Local application of medication with ultrasound.
Hood Larry (25652 Notingham Ct. Laguna Hills CA 92653-7504) Mendez Antonio G. (AV. Reforma No. 1277 Mexicali ; B. C. 21100 MXX), Method and apparatus for modifications of visual acuity by thermal means.
Berry Michael J. ; Hennings David R. ; Vassiliadis Arthur V., Method and apparatus for performing corneal reshaping to correct ocular refractive errors.
Mattson, Matthew S.; Kornfield, Julia A.; Schwartz, Daniel M.; Maloney, Robert K.; Grubbs, Robert H., Photochemical therapy to affect mechanical and/or chemical properties of body tissue.
Zeimer Ran C. (Chicago IL) Khoobehi Bahram (River Forest IL) Peyman Gholam A. (Chicago IL), System for selective release of liposome encapsulated material via laser radiation.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.